Charlotte Dyring at ExpreS2ion Biotechnologies (STO: EXPRS2)

Producer of non-viral insect cell expression system designed to provide the correct form of the desired protein to support malaria research and vaccine development

Contact

Firm

ExpreS2ion Biotechnologies (STO: EXPRS2)

Location

Italy

Investment Stage

Growth

Geographic Focus

ItalyEurope

About Charlotte Dyring

Enriching content...

Investment Focus

Manufacturing

Similar Investors in Europe

Grégoire Sentilhes at NextStage AM (PAR: NEXTS)

Software, Media • France

Anthony Acampora at Altaira Wealth Management SA

Wealth Management • Switzerland

Amber Ali at Altaira Wealth Management SA

Wealth Management • Switzerland

Armand Bach at Capital Initiative

Enterprise • France

Contact ExpreS2ion Biotechnologies (STO: EXPRS2)

Get in touch for investment criteria and partnership opportunities.

Contact